Lifeboat Foundation

You probably know the quote by Steve Jobs saying that death is life’s single best invention because it gets rid of the old and makes room for the new. This view is the core of another fairly common objection to rejuvenation, codename “cultural stagnation”.

Wouldn’t all those rejuvenated people, however physically young, be always old people “inside”, and drag everyone down with them into their anachronistic, surpassed ways of thinking, making it harder for fresh ideas to take hold, ultimately hindering social progress and our growth as a species? Maybe it’d be best not to take the risk, forget rejuvenation, and be content with old age as it is.

Well, try explaining to your grandfather that the reason he has to put up with heart disease is that we’re afraid people his age may all become troublemakers when you let them live too long.

Dr. Calos’s work has inspired us for over a decade: she has pioneered a radically novel approach to gene therapy that has the potential to overcome all the key obstacles that have held that field back for so long. We are delighted to welcome her to Berlin to discuss the latest advances in this technology.

https://www.undoing-aging.org/news/dr-michele-calos-to-speak…aging-2018

Doctor says test run on corpses last week helped explore technical issues and results will be published soon.

“How healthy are clones? What about clones of clones?”

This seems like a pretty silly way to go about testing this. I’d clone like 1,000 to 10,000 mice and track them down generations to see if there was anything abnormal. Then, 1,000 cloned rats. And, finally clone 100 monkeys.

Continue reading “World’s First Cloned Dog Has Been Cloned Again” »

A team of university scientists has developed the world’s first artificial kidney technology to be implanted in the body. Their bio-hybrid approach uses living kidney cells in tandem with a series of specialized microchips powered by the human heart to filter waste from the blood stream.

The National Kidney Foundation estimates that over 100,000 patients are on the waiting list for a donor kidney, and over 3,000 are added list each year. The average patient spends 3.6 years waiting for a viable transplant, and may be treated with dialysis while they wait, but only one in three dialysis patient survives longer than five years without a transplant.

Continue reading “World’s First Artificial Kidney Is All Set To Replace Dialysis in 2-3 Years. Here is how it works!” »

This effects whole families and their emotional well being!

Bill Gates shares his thoughts on Alzheimer’s disease and his hopes for accelerating progress to find a breakthrough.

Continue reading “Why I’m Digging Deep Into Alzheimer’s” »

“Increasingly, sophisticated and costly treatment are available to ever more limited and privileged segments of the population, and this raises questions about the sustainability of health care delivery and about what might be called a systemic tendency toward growing inequality in health care,” the pope said.

VATICAN CITY — Pope Francis on Thursday urged lawmakers to ensure that health care laws protect the “common good,” decrying the fact that in many places only the privileged can afford sophisticated medical treatments.

The comments came as U.S. lawmakers in Washington, D.C., have been debating how to overhaul the nation’s health insurance laws.

Continue reading “Pope to lawmakers: Protect all people with health care laws” »

Its developer iFlytek Co Ltd, a leading Chinese artificial intelligence company, said on Thursday that the robot scored 456 points, 96 points higher than the required marks.

The artificial-intelligence-enabled robot can automatically capture and analyze patient information and make initial diagnosis. It will be used to assist doctors to improve efficiency in future treatments, iFlytek said.

This is part of broader efforts by China to accelerate the application of AI in healthcare, consumer electronics, and other industries.

Continue reading “Chinese robot becomes world’s first machine to pass medical exam” »

Nathan Treff was diagnosed with type 1 diabetes at 24. It’s a disease that runs in families, but it has complex causes. More than one gene is involved. And the environment plays a role too.

So you don’t know who will get it. Treff’s grandfather had it, and lost a leg. But Treff’s three young kids are fine, so far. He’s crossing his fingers they won’t develop it later.

Now Treff, an in vitro fertilization specialist, is working on a radical way to change the odds. Using a combination of computer models and DNA tests, the startup company he’s working with, Genomic Prediction, thinks it has a way of predicting which IVF embryos in a laboratory dish would be most likely to develop type 1 diabetes or other complex diseases. Armed with such statistical scorecards, doctors and parents could huddle and choose to avoid embryos with failing grades.

Continue reading “Eugenics 2.0: We’re at the Dawn of Choosing Embryos” »